Showing results (11-20 of 116) with videos related to
Sort By:
Pageof 12
Current Drug Metabolism|October 8, 2003
Physiological approaches to the prediction of drug-drug interactions in study populationsJ Y Chien, M A Mohutsky, S A WrightonAntimicrobial Agents and Chemotherapy|February 1, 1993
Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human liversT D Lindstrom, B R Hanssen, S A WrightonBiochemical Pharmacology|July 7, 1992
Detection of human lung cytochromes P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIAC W Wheeler, S A Wrighton, T M GuenthnerCarcinogenesis|October 1, 1983
Demonstration of two unique metabolites of arachidonic acid from phorbol ester-stimulated bovine lymphocytesS A Wrighton, J K Pai, G C MuellerBiochemical Pharmacology|September 13, 1996
Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomesG R Jang, S A Wrighton, L Z BenetArchives of Biochemistry and Biophysics|December 1, 1986
Purification and characterization of aldo-keto reductases from gerbil liver: immunochemical evidence for related proteins in other mammalian speciesD T Molowa, S A Wrighton, P S GuzelianThe Journal of Pharmacology and Experimental Therapeutics|September 22, 1999
Three-dimensional-quantitative structure activity relationship analysis of cytochrome P-450 3A4 substratesS Ekins, G Bravi, J H Wikel, et al.Pharmacogenetics|June 1, 1997
Examination of purported probes of human CYP2B6S Ekins, M VandenBranden, B J Ring, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1993
Stereo- and regioselective N- and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomesJ R Cashman, Z Yang, L Yang, et al.Pharmacogenetics|February 1, 1996
Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitorM VandenBranden, B J Ring, S N Binkley, et al.Pageof 12